Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylergonovine for PPH Prevention in Non-Elective C-Sections
NCT03904446Phase 4Completed
- Start
- Jun 2019
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of methylergometrine in postpartum hemorrhage (PPH) and uterine atony. Primary endpoint: Number of Participants With Need for Additional Uterotonics at 24 hours. Started Jun 2019; status: completed.
02
Drugs
methylergometrine
03
Conditions
postpartum hemorrhage (PPH)uterine atony
Beyond the preview
Go deeper on NCT03904446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03904446.